Explore Content
Explore the most recently added content
Prescribing Information can be found through the links in the Product Cards at the bottom of the page
Support for your Patients
Discover the selection of support materials for patients from different therapeutic areas
Our Products

MAT-XU-2200954 (v1.0)
Date of preparation: September 2022
---Copy.png/jcr:content/AUBAGIO_logo_RGB%20(1)%20-%20Copy.png)
Prescribing Information GB
Prescribing Information NI
MAT-XU-2200676 (v3.0)
Date of preparation: August 2022
.png/jcr:content/Cablivi-logo%20(3).png)
Prescribing Information GB
Prescribing Information NI
MAT-GB-2105168 (v2.0)
Date of preparation: November 2022

Prescribing Information GB
Prescribing Information NI
MAT-XU-2204064 (v2.0)
Date of preparation: January 2023

Prescribing Information GB
Prescribing Information NI
MAT-XU-2204065 (v2.0)
Date of preparation: January 2023

Clexane
enoxaparin
Prescribing Information UK
MAT-XU-2204397 (v1.0)
Date of preparation: December 2022

MAT-GB-2105812 (v2.0)
Date of preparation: August 2022
.png/jcr:content/Lemtrada-triangle-logo-product-card%20(1).png)
Prescribing Information GB
Prescribing Information NI
MAT-XU-2200680 (v2.0)
Date of preparation: August 2022
.png/jcr:content/Myozyme-logo%20(1).png)
MAT-GB-2105179 (v3.0)
Date of preparation: August 2022

PRALUENT
alirocumab
Prescribing Information GB
Prescribing Information NI
MAT-XU-2204604 (v1.0)
Date of preparation: October 2022
▼ This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.
MAT-GB-2105264 (v4.0)
Date of preparation: December 2022